Related Experiment Video
Updated: Dec 28, 2025

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Characterization of Admission Medication Reconciliations Performed by Pharmacists in a Pediatric Institution:
Insights
Pediatric medication reconciliation (MedRec) identified risk factors for pharmacist interventions. Patients with multiple home medications, especially those in the PICU or with cardiac/endocrine issues, require prioritized MedRec to prevent adverse drug events.
Area of Science:
- Pediatric pharmacology
- Patient safety
- Healthcare quality improvement
Background:
- Children face higher risks of medication errors and adverse effects than adults.
- Proactive identification of at-risk pediatric patients is recommended to prevent medication-related adverse events.
- This study aimed to identify risk factors in admitted pediatric patients necessitating pharmacist intervention during medication reconciliation (MedRec).
Purpose of the Study:
- To evaluate pediatric admissions to identify specific risk factors.
- To determine factors that require pharmacist intervention during the MedRec process.
- To enhance patient safety through targeted medication reconciliation.
Main Methods:
- Prospective study of pediatric patient admissions until 500 encounters were achieved.
- Pharmacy staff collected medication histories; pediatric pharmacists performed MedRec.
- Primary outcome: identification of high-risk transition of care factors based on pharmacist interventions.
Main Results:
- 331 interventions were made for 127 patients; 59.2% were moderate or significant severity.
- Patients with ≥2 home medications were more likely to need any intervention (p < 0.0001).
- Patients with ≥5 home medications had a higher likelihood of significant interventions.
Conclusions:
- Identifying patients with multiple home medications enables focused intervention efforts.
- Prioritize MedRec for PICU admissions or patients with cardiology/endocrinology diagnoses due to higher medication needs.
- Tailor MedRec strategies to institutional resources and quality assessments for optimal pediatric patient safety.
Background:
Compared with adults, children may be at greater risk of medication errors and potential adverse effects. The American Academy of Pediatrics recommends developing mechanisms for proactively identifying patients at risk for medication-related adverse events and failed reconciliation. This study's primary purpose was to evaluate pediatric patients admitted to identify risk factors requiring pharmacist intervention during medication reconciliation (MedRec).
Methods:
This prospective study included pediatric patients admitted during the study time frame until the target population of 500 patient encounters was achieved. During each admission, pharmacy staff completed a medication history, after which a pediatric pharmacist completed a MedRec, as is standard hospital practice. The primary outcome was identification of factors for high-risk transitions of care during pediatric admissions based on the need for pharmacist interventions during the MedRec process.
Results:
In total, 331 interventions were made for 127 patients (median 2; range, 1-12). Of the 331 interventions, 196 (59.2%) were classified as being of moderate or significant severity. Although patients with at least 2 home medications were significantly more likely to require any intervention (p < 0.0001), patients with 5 or more home medications were more likely to have a significant intervention.
Conclusion:
Identifying patients with home medications could allow for focused efforts to intervene. Also, patients admitted to the PICU or those with cardiology- or endocrinology-related diagnoses should be prioritized for MedRec process, because of the likelihood of requiring multiple home medications. This strategy should be tailored to individual pediatric institutions based on internal quality control assessments and available resources.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Drug Dosing: Infants and Children
Dosage Regimens: Partial Pharmacokinetic Parameters

